This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Bristol Myers Squibb and Pfizer will begin offering ...
The drugmakers Bristol-Myers Squibb and Pfizer plan to sell the widely used blood thinner Eliquis directly to patients at a discounted cash price—a move that follows the Trump administration’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback